Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice

Highly conserved intracellular proteins from Leishmania have been described as antigens in natural and experimental infected mammals. The present study aimed to evaluate the antigenicity and prophylactic properties of the Leishmania infantum Poly (A) binding proteins (LiPABPs). Three different members of the LiPABP family have been described. Recombinant tools based on these proteins were constructed: recombinant proteins and DNA vaccines. The three recombinant proteins were employed for coating ELISA plates. Sera from human and canine patients of visceral leishmaniasis and human patients of mucosal leishmaniasis recognized the three LiPABPs. In addition, the protective efficacy of a DNA vaccine based on the combination of the three Leishmania PABPs has been tested in a model of progressive murine leishmaniasis: BALB/c mice infected with Leishmania major. The induction of a Th1-like response against the LiPABP family by genetic vaccination was able to down-regulate the IL-10 predominant responses elicited by parasite LiPABPs after infection in this murine model. This modulation resulted in a partial protection against L. major infection. LiPABP vaccinated mice showed a reduction on the pathology that was accompanied by a decrease in parasite burdens, in antibody titers against Leishmania antigens and in the IL-4 and IL-10 parasite-specific mediated responses in comparison to control mice groups immunized with saline or with the non-recombinant plasmid. The results presented here demonstrate for the first time the prophylactic properties of a new family of Leishmania antigenic intracellular proteins, the LiPABPs. The redirection of the immune response elicited against the LiPABP family (from IL-10 towards IFN-γ mediated responses) by genetic vaccination was able to induce a partial protection against the development of the disease in a highly susceptible murine model of leishmaniasisThe study was supported in Spain by grants from Ministerio de Ciencia e Innovación FIS PI11/00095 and FISPI14/00366 from the Instituto de Salud Carlos III within the Network of TropicalDiseases Research (VI P I+D+I 2008-2011, ISCIII -Subdirección General de Redes y Centros de Investigación Cooperativa (RD12/0018/0009)). This work was also supported in Brazil by a grant from CNPq (Ciencia sem Fronteiras-PVE 300174/2014-4). A CBMSO institutional grant from Fundación Ramón Areces is also acknowledged. EAFC is a grant recipient of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip

Impact of different light characteristics on the growth and lipid content of diatom Phaeodactylum tricornutum transconjugant strains

Abstract Light regulates important metabolic processes in microalgal cells, which can further impact the metabolism and the accumulation of biomolecules such as lipids, carbohydrates, and proteins. Different characteristics of light have been studied on various strains of the model diatom Phaeodactylum tricornutum, but not on transconjugant cells and information on wild-type strains is still limited. Therefore, we studied the impact of different light characteristics such as spectral quality, light intensity and light shift on the growth, and the composition in lipids and fatty acids of P. tricornutum cells to provide a comprehensive context for future applications. Initially, we tested the impact of spectral quality and light intensity on P. tricornutum transformed with an episomal vector (Ptev), harboring the resistance gene Sh ble. Results indicated that Ptev cells accumulated more biomass and overall lipids in spectral quality Red 1 (R1: 34% > 600 nm > 66%) more effectively as compared to Red 2 (R2: 8% > 600 nm > 92%). It was also detected that cell granularity was higher in R1 as compared to R2. Furthermore, by testing two light intensities 65 μmol·m-2·s-1 and 145 μmol·m-2·s-1 light, it was observed that 145 μmol·m-2·s-1 led to an increase in growth trend, total biomass and lipid content. Combining spectral qualities and light intensities, we show that the lipid accumulation raised by 2.8-fold. Studying the light intensity and spectral quality allowed us to optimize the light conditions to R1 spectral quality and light intensity 145 μmol·m-2·s-1. These initial results showed that red light R1 at 145 μmol·m-2·s-1 was the best condition for biomass and total lipids accumulation in Ptev cells. Next, we further combined these two-light optimizations with a third light characteristics, i.e. light shift, where the cultures were shifted during the early stationary phase to a different light environment. We studied Red light shift (Rs) to investigate how light condition variations impacted P. tricornutum transconjugants Ptev and with an episomal vector containing the reporter gene YFP (PtYFP). We observed that Rs induced growth and fatty acid eicosapentaenoic acid (EPA) in Ptev as compared to PtYFP. Altogether, the study shows that red light shift of R1 at 145 μmol·m-2·s-1 promoted biomass and total lipids accumulation in Ptev and PtYFP cells. The study provides a comprehensive approach to using different light characteristics with the aim to optimize growth and lipids, as well as to fatty acid production

In vivo thrombin activity in the diatom Phaeodactylum tricornutum: Biotechnological insights

Abstract Diatoms are responsible for 20% of global carbon dioxide fixation and have significant potential in various biotechnological and industrial applications. Recently, the pennate diatom Phaeodactylum tricornutum has emerged as a prominent platform organism for metabolic engineering and synthetic biology. The availability of its genome sequence has facilitated the development of new bioengineering tools. In this study, we used in silico analyses to identify sequences potentially encoding thrombin-like proteins, which are involved in recognizing and cleaving the thrombin sequence LVPRGS in P. tricornutum. Protein structure prediction and docking studies indicated a similar active site and ligand positioning compared to characterized human and bovine thrombin. The evidence and efficiency of the cleavage were determined in vivo using two fusion-protein constructs that included YFP to measure expression, protein accumulation, and cleavage. Western blot analysis revealed 50–100% cleavage between YFP and N-terminal fusion proteins. Our findings suggest the existence of a novel thrombin-like protease in P. tricornutum. This study advances the application of diatoms for the synthesis and production of complex proteins and enhances our understanding of the functional role of these putative thrombin sequences in diatom physiology. Key points: • Protein structure predictions reveal thrombin-like active sites in P. tricornutum. • Validated cleavage efficiency of thrombin-like protease on fusion proteins in vivo. • Study advances bioengineering tools for diatom-based biotechnological applications

Multifactorial interaction and influence of culture conditions on yellow fluorescent protein production in Phaeodactylum tricornutum

Abstract Phaeodactylum tricornutum is a promising host for light-driven synthesis of heterologous proteins. However, the marine cold-water environment and alkaline-acidic pH shifts in the culture, necessitated by the diatom's growth requirements. In this study, we analyzed the influence of growth condition on maturation and dynamics of the yellow fluorescent protein (YFP) in episomal-transformant P. tricornutum. A mathematical model was developed to detect the parameters that affect biomass and YFP production. Optimized conditions increased YFP mean fluorescence intensity (MFI) per cell by 4.2-fold (3.6 ± 0.6 to 15.4 ± 1.1) and total protein levels in the culture by 1.8-fold (123 ± 4 to 219 ± 9 µg L−1), without affecting biomass. YFP stability studies in P. tricornutum showed that the ubiquitin–proteasome system contributes the degradation of the recombinant protein, whereas newly synthesized YFP remains stable for up to 12 h. This optimization provides insights into the fluorescent protein-based heterologous production in diatoms

Successful reversal of transgene silencing in Chlamydomonas reinhardtii

Abstract Chlamydomonas reinhardtii has been successfully engineered to produce compounds of interest following transgene integration and heterologous protein expression. The advantages of this model include the availability of validated tools for bioengineering, its photosynthetic ability, and its potential use as biofuel. Despite this, breakthroughs have been hindered by its ability to silence transgene expression through epigenetic changes. Histone deacetylases (HDAC) are main players in gene expression. We hypothesized that transgene silencing can be reverted with chemical treatments using HDAC inhibitors. To analyze this, we transformed C. reinhardtii, integrating into its genome the mVenus reporter gene under the HSP70-rbcs2 promoter. From 384 transformed clones, 88 (22.9%) displayed mVenus positive (mVenus+) cells upon flow-cytometry analysis. Five clones with different fluorescence intensities were selected. The number of integrated copies was measured by qPCR. Transgene expression levels were followed over the growth cycle and upon SAHA treatment, using a microplate reader, flow cytometry, RT-qPCR, and western blot analysis. First, we observed that expression varies with the cell cycle, reaching a maximum level just before the stationary phase in all clones. Second, we uncovered that supplementation with HDAC inhibitors of the hydroxamate family, such as vorinostat (suberoylanilide-hydroxamic-acid, SAHA) at the initiation of culture increases the frequency (% of mVenus+ cells) and the level of transgene expression per cell over the whole growth cycle, through histone deacetylase inhibition. Thus, we propose a new tool to successfully trigger the expression of heterologous proteins in the green algae C. reinhardtii, overcoming its main obstacle as an expression platform

Extrachromosomal expression of functional Cannabis sativa cannabidiolic acid synthase in Phaedodactylum tricornutum

Abstract Cannabis sativa's cannabidiolic acid (CBDA) offers significant therapeutic potential without inducing psychotropic effects but is typically found as part of a complex mixture of metabolites in plant extracts. Using a heterologous expression platform could allow the production of pure CBDA. Here, we propose to express CBDA synthase (CBDAS) in Phaeodactylum tricornutum. Episomes carrying CBDAS variants, incorporating the native signal peptide (CBDAS) or the highly abundant secreted protein 1 secretory signal peptide (SP:CBDAS) were constructed. CBDAS variants were tagged with the yellow fluorescent protein (YFP), introduced into the marine diatom, and screened by fluorescence. Confocal microscopy revealed that CBDAS and SP:CBDAS arranged in aggregated structures indicative of secretory pathway involvement. Western blot assays confirmed whole construct accumulation intracellularly, while soluble YFP was detected extracellularly. Finally, enzymatic assays showed CBDA production by both CBDAS and SP:CBDAS strains, confirming the potential of P. tricornutum as a platform for cannabinoid biosynthesis

Cancer de la prostate résistant à la castration (CRPC). Revue de la littérature en 2016

Introduction : Le cancer de la prostate en Tunisie est la troisième cause de mortalité par cancer après le cancer du poumon et les cancers colorectaux. L'avènement récent des hormonothérapies de nouvelle génération a révolutionné la prise en charge du cancer de la prostate résistant à la castration (CPRC). Plusieurs options thérapeutiques sont désormais disponibles en pré et en post Docetaxel. L’objectif de notre travail était d’étudier les différentes stratégies thérapeutiques dans le CPRC. Méthodes : Nous avons effectué une recherche bibliographique sur Pubmed, Medline, Cochrane   et en se référant aux recommandations internationales des sociétés savantes : AFU, EAU, ESMO, NCCN concernant les protocoles thérapeutiques des CPRC. Résultats : De nombreuses nouvelles classes thérapeutiques sont à différents stades de leur développement pour le CPRC. La connaissance de la biologie tumorale a mis en évidence l’implication de nouvelles cibles thérapeutiques comme le récepteur aux androgènes. Selon cette revue de la littérature, des immunothérapies, de nouvelles hormonothérapies, de nouveaux anti-androgènes, des thérapies ciblées et de nouveaux traitements ciblant l’os métastatique ont enrichis-la prise en charge thérapeutique des CPRC. Conclusion : Les progrès dans la prise en charge médicale du patient atteint de CPRC sont en nette progression et ce depuis 2004. L’année 2010 a été particulièrement riche en nouvelles thérapies, avec notamment les hormonothérapies de deuxième génération utilisées en pré et post Docetaxel. Tout le challenge actuel est de proposer la séquence thérapeutique optimale pour chaque patient, d’où le concept de médecine personnalisée.

Tumeur neuro-ectodermique primitive du rein avec insuffisance rénale

Introduction : Les Tumeurs neuroectodermiques périphériques (PNET) ou le sarcome d'Ewing est un cancer qui se développe habituellement dans les os et la localisation extrasquelettique est rare. Les PNET de localisation rénale sont rares et se caractérisent par une évolution clinique agressive et un mauvais pronostic. Seuls quelques cas de PNET rénaux avec insuffisance rénale ont été rapportés dans la littérature à ce jour.  Cas clinique : Nous présentons un cas de PNET rénal chez un homme de 48 ans sans antécédents médicaux, qui présentait une douleur au flanc droit, imitant des coliques nephretiques. Une échographie abdominale a montré une masse rénale droite.  La tomodensitométrie a montré une masse du rein droit de 23x9 cm associée à une carcinose péritonéale, la tumeur été localement avancé avec invasion vasculaire et des structures adjacentes. L'analyse histologique a trouvé de petites cellules rondes monomorphes qui forment des rosettes. à l’immunohistochimie, les cellules tumorales sont fortement positifs pour le CD99 et la vimentine confirmant le diagnostic de PNET. Le patient a développé une insuffisance rénale au début de l'évolution de la maladie qui nous a empêchés de réaliser le bilan d’extension de la maladie et de prescrire une chimiothérapie. Le patient est décédé de sa maladie trois mois plus tard.Discussion : Les Tumeur neuroectodermique périphérique (PNET) de localisation rénale surviennent généralement pendant l'enfance, l'adolescence ou chez le jeune adulte ce qui n’est pas le cas de notre patient (48 ans). L’insuffisance rénale en association avec les PNET rénaux a été rapportée précédemment dans seulement quelques cas pédiatriques, mais pas dans la population adulte. cette insuffisance rénale peut être expliquer par: d'une part le thrombus direct qui envahit la veine rénale (20 à 30% des cas en pédiatrie), d'autre part l'étendue de la tumeur elle-même dans le rein et enfin la compression  par les adénopathies régionales. La présence d'une fonction rénale altérée complique encore la gestion de ces patients à risque élevé avant le traitement et également après le début de la chimiothérapie. Et ceci est un obstacle à l'utilisation d’une chimiothérapie potentiellement néphrotoxiques et de produit de contraste pour l'imagerie. Devrions-nous utiliser l'échographie, la tomodensitométrie sans produit de contraste ou l’imagerie par résonance magnétique pour la stadification et le suivi ? D'autres recherches peuvent répondre à ces questions.Conclusion : Les PNET de localisation rénale doivent être envisagées dans les tumeurs rénales de tous âges, mais plus particulièrement chez les enfants et les jeunes adultes. Cette tumeur a de nombreuses similitudes avec d'autres tumeurs rénales, il est important de diagnostiquer cette entité tôt avant l’apparition des complications et principalement l’insuffisance rénale

Impact of heterologous expression of Cannabis sativa tetraketide synthase on Phaeodactylum tricornutum metabolic profile

Abstract Background Pharmaceutical safety is an increasing global priority, particularly as the demand for therapeutic compounds rises alongside population growth. Phytocannabinoids, a class of bioactive polyketide molecules derived from plants, have garnered significant attention due to their interaction with the human endocannabinoid system, offering potential benefits for managing a range of symptoms and conditions. Traditional extraction from cannabis plants poses regulatory, environmental, and yield-related challenges. Consequently, microbial biosynthesis has emerged as a promising biotechnological alternative to produce cannabinoids in a controlled, scalable, and sustainable manner. Developing diatom-based biofactories represent a crucial step in advancing this biotechnology, enabling the efficient production of high-valued compounds such as cannabinoids. Results We engineered the diatom Phaeodactylum tricornutum, a unicellular photosynthetic model organism prized for its naturally high lipid content, to produce olivetolic acid (OA), a key metabolic precursor to most cannabinoids. The genes encoding tetraketide synthase and olivetolic acid cyclase from cannabis were cloned onto episomal vectors and introduced using bacterial conjugation in two separate P. tricornutum transconjugant lines to evaluate enzyme activity and OA production in vivo. Both genes were successfully expressed, and the corresponding enzymes accumulated within the transconjugant lines. However, despite testing the cell extracts individually and in combination, OA accumulation was not detected suggesting potential conversion or utilization of OA by endogenous metabolic pathways within the diatoms. To investigate this further, we analyzed the impact of CsTKS expression on the diatom’s metabolome, revealing significant alterations that may indicate metabolic flux redirection or novel pathway interactions. Conclusions Our study demonstrates the successful expression of cannabinoid biosynthetic genes in P. tricornutum but highlights challenges in OA accumulation, likely due to endogenous metabolic interactions. These findings underscore the complexity of metabolic engineering in diatoms and suggest the need for further pathway optimization and metabolic flux analysis to achieve efficient cannabinoid biosynthesis. This research contributes to advancing sustainable biotechnological approaches for cannabinoid production

Diatoms biotechnology: various industrial applications for a greener tomorrow

The benefits of the complex microscopic and industrially important group of microalgae such as diatoms is not hidden and have lately surprised the scientific community with their industrial potential. The ability to survive in harsh conditions and the presence of different pore structures and defined cell walls have made diatoms ideal cell machinery to produce a variety of industrial products. The prospect of using a diatom cell for industrial application has increased significantly in synch with the advances in microscopy, metabarcoding, analytical and genetic tools. Furthermore, it is well noted that the approach of industry and academia to the use of genetic tools has changed significantly, resulting in a well-defined characterization of various molecular components of diatoms. It is possible to conduct the primary culturing, harvesting, and further downstream processing of diatom culture in a cost-effective manner. Diatoms hold all the qualities to become the alternative raw material for pharmaceutical, nanotechnology, and energy sources leading to a sustainable economy. In this review, an attempt has been made to gather important progress in the different industrial applications of diatoms such as biotechnology, biomedical, nanotechnology, and environmental technologies